Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

Ankara Training and Research Hospital

Status: Unknown

Conditions: Erectile Dysfunction

Treatments: Drug: tadalafil; Diagnostic Test: Endocan

Study type: Interventional

Funder types: Other

Identifiers

NCT05109377

E-93471371-514.10

Details and patient eligibility

About

The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.

Full description

The investigators will include at least 90 patients in study. Blood tests will taken before and after tadalafil treatment and will store at -80 celcius degree.

Enrollment: 90 estimated patients

Sex: Male

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with erectile dysfuction

Exclusion criteria

• Psychogenic erectile dysfunction
• Erectile dysfunction associated with hormonal disorders
• Drug related erectile dysfunction

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

90 participants in 2 patient groups

5mg tadalafil

Other group

Description:

5mg tadalafil

Treatment:

Diagnostic Test: Endocan

Drug: tadalafil

20mg tadalafil

Other group

Description:

20 mg tadalafil

Treatment:

Diagnostic Test: Endocan

Drug: tadalafil